Premium
CX Partners, a mid-market private equity firm, has started the process to divest its majority stake in Veeda Clinical Research, an independent clinical research organization based in Ahmedabad, a media report said. The anticipated valuation of Veeda Clinical Research is between $600 million (Rs 5,000 crore) to $650 million, Moneycontrol reported, citing ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.